Richard E. Davis

Richard E. Davis has filed trades across 2 companies (mainly through SEC (Form 4)), most often in NMT Medical Inc and Arch Therapeutics, Inc. In total, 68 filings cover trades dated from 11 January 2006 to 19 July 2018.

In open-market terms, that means 13 purchases worth €165k on one side and 39 sales worth €581k on the other. Netting one side against the other leaves €416k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants and 8 option exercises.

A typical purchase (the median) is worth €7,387.

Most recently, on 20 July 2018, the filings show a share grant in Arch Therapeutics, Inc. The most recent open-market purchase was published on 18 February 2010, 6,091 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.